Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Presentation skills

Tumour-infiltrating CD8+ T cells are often located within stromal-rich areas in the tumour and thus are in close contact with cancer-associated fibroblasts (CAFs). New research by Lakins et al. shows that CAFs are able to inhibit tumour-antigen-specific T cell activity through engaging in antigen processing and immune checkpoint ligand expression. CAFs isolated from murine lung tumours processed and cross-presented peptides of tumour cell-specific ovalbumin (OVA). In co-culture, tumour cell survival was significantly increased when T cells were pre-conditioned with OVA-presenting CAFs, owing to a reduction in T cell viability. This effect was dependent on increased programmed cell death 1 ligand 2 (PDL2) and FAS ligand expression on CAFs compared with normal fibroblasts, the inhibition of which led to reduced tumour growth in a mouse model.


  1. 1

    Lakins, M. A. et al. Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells. Nat. Commun. 9, 948 (2018)

    Article  Google Scholar 

Download references


Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Harjes, U. Presentation skills. Nat Rev Cancer 18, 207 (2018).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing